Social health in endocrinology: A conference report
Sir, Psychosocial and public health related aspects of health are important not only in diabetes, but also in endocrinology as well. The first South Asian Federation of Endocrine Societies (SAFES) conference, held at Hyderabad, India, on 17 and 18 August 2013, acknowledged this reality.
Many of the topics discussed at the 2 days long conference, conducted in three parallel halls, covered the psychosocial and public health dimension of endocrinology, including diabetology.
These included the Presidential Oration, delivered by Dr. Sarita Bajaj, which called for national screening programs for congenital hypothyroidism, to tackle this easily preventable public endocrine health problem.
A session on gender and endocrinology focused upon the psychoneuroendocrine aspects of female sexuality, gender dysphoria and menopause. Psychosocial issues were also discussed at length in symposia including pediatric endocrinology and andrology.
In the sessions on diabetes, patient-oriented themes such as medical nutrition therapy, hypoglycemia and management during Ramadan were covered. The applicability of patientfriendly guidelines on the use of premixed insulin to South Asia was critically analyzed and a suggestion for regional guidelines made.
Other talks highlighted the public health impact of bone disorders and diabetes in South Asia, calling for action to prevent these endocrine morbidities.
Detailed emphasis on these issues is important, especially in South Asia, which bears the brunt of the pandemic of diabetes and its associated complications. SAFES' quest to be known as a global leader in endocrine care will not be achieved unless adequate attention is paid to the psychosocial dimension of health (without, of course, neglecting the biological domain).
The Scientific Committee, chaired by Dr. Subhankar Chowdhary (India), co-chaired by Dr. Faruque Pathan (Bangladesh) and ably assisted by Dr. Kaushik Pandit (India) and Dr. Sujoy Ghosh (India) deserves the credits for highlighting these important, yet often neglected, aspects of endocrine health.
Smoking cessation in diabetics: Need of the hour
Sir, Through this letter, I would like to draw attention of the readers towards a very important lacuna in diabetes management i.e., smoking cessation. Although much emphasis is given on educating the diabetic patients about the importance of exercise, diet control and timely drug therapy, but the issue of importance of smoking cessation remains relatively unaddressed.
Smoking in India has been prohibited in public since 2 nd October 2008 under Prohibition of Smoking in Public Places Rules, 2008. Many districts in Haryana have imposed a ban on hookah smoking as well. [1, 2] But sadly, even these laws have not been able to change the scenario much. Smoking is still widely prevalent in the society. According to a World Bank Report in 2009, 26.25% of males and 3.64% of females in India smoke tobacco in one or the other form such as bidis, cigarettes, cigars, hookah or chillum. Another dark side of the scenario is that the smoking prevalence in women has even increased when compared with previous years. [3, 4] Smoking not only provokes the onset of diabetes in normal subjects by causing deterioration of glucose metabolism, but also worsens type 2 diabetes by causing greater insulin resistance, impaired beta-cell function, less insulin secretion and chronic inflammation. It aggravates the macro-or micro-vascular complications of diabetes such as nephropathy, neuropathy and coronary artery disease. [5, 6] Thus, there is a pressing need to spread awareness among the public and especially the diabetic individuals regarding the importance of smoking cessation. It is the duty of health-care providers to advise the diabetic patients about the benefits of stopping smoking and the options available, which can help them to quit the habit. In nutshell, smoking cessation programs should be made an integral part of diabetes management. Without this, diabetes care is largely incomplete.
